Observational Study
Copyright ©The Author(s) 2021.
World J Gastrointest Oncol. Jan 15, 2021; 13(1): 37-57
Published online Jan 15, 2021. doi: 10.4251/wjgo.v13.i1.37
Figure 7
Figure 7 Correlation of the miRNA-based signature with tumor mutation burden values and immune checkpoint molecules (programmed death-1, programmed death ligand-1, and cytotoxic T lymphocyte associated antigen 4). TMB: Tumor mutation burden; PD-1: Programmed death-1; PD-L1: Programmed death ligand-1; CTLA4: Cytotoxic T lymphocyte associated antigen 4.